134 related articles for article (PubMed ID: 4590252)
1. Liver scan in hyperlipoproteinemia.
Sachs BA; Bardfeld PA; Bodian JE; Sugarman LA; Hellman L
JAMA; 1974 Feb; 227(8):907-10. PubMed ID: 4590252
[No Abstract] [Full Text] [Related]
2. Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.
Glueck CJ; Ford S; Scheel D; Steiner P
JAMA; 1972 Nov; 222(6):676-81. PubMed ID: 4562098
[No Abstract] [Full Text] [Related]
3. Treatment of hypercholesterolaemia with colestipol: a bile sequestrating agent.
Nye ER; Jackson D; Hunter JD
N Z Med J; 1972 Jul; 76(482):12-6. PubMed ID: 4344110
[No Abstract] [Full Text] [Related]
4. Comparative study of several hypolipidemic agents related to clofibrate.
Beaumont V; Buxtorf JC; Jacotot B; Beaumont JL
Atherosclerosis; 1974; 20(2):141-53. PubMed ID: 4369878
[No Abstract] [Full Text] [Related]
5. A comparative study of a new drug MK 185 with clofibrate in the treatment of hyperlipidaemias.
Jepson EM; Small E; Grayson MF; Bance G; Billimoria JD
Atherosclerosis; 1972; 16(1):9-14. PubMed ID: 4341723
[No Abstract] [Full Text] [Related]
6. Ultracentrifugal demonstration of floating beta lipoproteins in type 3 hyperlipoproteinemia. Diagnostic value.
Aubry F; Lapierre YL; Noël C; Davignon J
Ann Intern Med; 1971 Aug; 75(2):231-7. PubMed ID: 5558651
[No Abstract] [Full Text] [Related]
7. Colestipol therapy of hyperlipidemia in man.
Sachs BA; Wolfman L
Proc Soc Exp Biol Med; 1974 Dec; 147(3):694-7. PubMed ID: 4445156
[No Abstract] [Full Text] [Related]
8. Hyperlipoproteinemia. 3. Drug therapy.
LaRosa JC
Postgrad Med; 1972 Aug; 52(2):128-32. PubMed ID: 5047023
[No Abstract] [Full Text] [Related]
9. Response of hyperlipoproteinemia to colestipol.
Sachs BA; Wolfman L
N Y State J Med; 1973 May; 73(9):1068-70. PubMed ID: 4512165
[No Abstract] [Full Text] [Related]
10. [Treatment of primary hyperlipoproteinaemia types, IIa, IIb, 3 and IV with clofibrate (author's transl)].
von Löwis P; Klemens UH
Dtsch Med Wochenschr; 1973 Dec; 98(49):2328-33. PubMed ID: 4357927
[No Abstract] [Full Text] [Related]
11. Colestipol and clofibrate in hypercholesterolemia.
Dujovne CA; Hurwitz A; Kauffman RE; Azarnoff DL
Clin Pharmacol Ther; 1974 Aug; 16(2):291-6. PubMed ID: 4604239
[No Abstract] [Full Text] [Related]
12. Type IV hyperlipoproteinemia. Clofibrate without dietary therapy.
Zelis R; Amsterdam EA; Spann JF; Mason DT
JAMA; 1972 Oct; 222(3):326-8. PubMed ID: 4566727
[No Abstract] [Full Text] [Related]
13. Controlled clinical trial of a new bile acid-sequestering resin, colestipol, in the treatment of hypercholesterolaemia.
Miller NE; Clifton-Bligh P; Nestel PJ; Whyte HM
Med J Aust; 1973 Jun; 1(25):1223-7. PubMed ID: 4579666
[No Abstract] [Full Text] [Related]
14. Effects of oxandrolone on plasma lipoproteins and the intravenous fat tolerance in man.
Olsson AG; Orö L; Rössner S
Atherosclerosis; 1974; 19(2):337-46. PubMed ID: 4360244
[No Abstract] [Full Text] [Related]
15. The uricosuric action of halofenate (MK-185) in patients with hyperuricemia or uncomplicated primary gout and hyperlipidemia.
Hutchison JC; Wilkinson WH
Atherosclerosis; 1973; 18(3):353-62. PubMed ID: 4584481
[No Abstract] [Full Text] [Related]
16. Treatment of hypertriglyceridemia with tibric acid and clofibrate. Cross-over studies, effects on lipoproteins and absence of post-drug rebound.
Smith FR; Noble RP; Goodman DS
Atherosclerosis; 1978 Mar; 29(3):345-54. PubMed ID: 666884
[No Abstract] [Full Text] [Related]
17. Heterogeneity on familial hyperlipoproteinemia type II on the basis of fasting plasma triglyceride-cholesterol ratio and plasma cholesterol response to ethyl p-chlorophenoxyisobutyrate.
Davignon J; Aubry F; Noël C; Lapierre Y; Lafortune M
Rev Can Biol; 1971 Dec; 30(4):307-18. PubMed ID: 5135408
[No Abstract] [Full Text] [Related]
18. Treatment of primary hyperlipoproteinaemias with a tetralin derivative (Su-13'437).
Fellin R; Fedele D; Bagnariol G; Pagnan A; Crepaldi G
Atherosclerosis; 1973; 17(3):383-8. PubMed ID: 4577009
[No Abstract] [Full Text] [Related]
19. Hypolipidemic drugs and hyperlipoproteinemia.
Levy RI; Langer T
Ann N Y Acad Sci; 1971 Jul; 179():475-80. PubMed ID: 4941915
[No Abstract] [Full Text] [Related]
20. Clinical evaluation of MK-185: a new hypolipidemic drug.
Sirtori C; Hurwitz A; Sabih K; Azarnoff D
Lipids; 1972 Feb; 7(2):96-9. PubMed ID: 4551950
[No Abstract] [Full Text] [Related]
[Next] [New Search]
